174 related articles for article (PubMed ID: 18408223)
1. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
[TBL] [Abstract][Full Text] [Related]
2. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy.
Doi M; Okamoto Y; Yamauchi M; Naitou H; Shinozaki K
Int J Clin Oncol; 2012 Oct; 17(5):528-31. PubMed ID: 22127348
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases.
Han JY; Nava-Ocampo AA; Kim TJ; Shim JU; Park CT
Reprod Toxicol; 2005; 19(4):557-61. PubMed ID: 15749271
[TBL] [Abstract][Full Text] [Related]
5. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
6. Endodermal sinus tumor in pregnancy.
Malhotra N; Sood M
Gynecol Oncol; 2000 Aug; 78(2):265-6. PubMed ID: 10926819
[No Abstract] [Full Text] [Related]
7. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
8. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.
Brown J; Shvartsman HS; Deavers MT; Ramondetta LM; Burke TW; Munsell MF; Gershenson DM
Gynecol Oncol; 2005 May; 97(2):489-96. PubMed ID: 15863149
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of patients with yolk sac tumors of the ovary.
Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
[TBL] [Abstract][Full Text] [Related]
10. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
11. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.
Kanazawa K; Suzuki T; Sakumoto K
Am J Clin Oncol; 2000 Jun; 23(3):244-8. PubMed ID: 10857886
[TBL] [Abstract][Full Text] [Related]
15. Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina.
Tao T; Yang J; Cao D; Guo L; Chen J; Lang J; Shen K
Gynecol Oncol; 2012 May; 125(2):358-61. PubMed ID: 22178761
[TBL] [Abstract][Full Text] [Related]
16. [Three cases of resected primary mediastinal yolk sac tumor following six courses of bleomycin, etoposide and cisplatin (BEP) combination chemotherapy].
Fujita A; Ohbuchi Y; Morikawa T; Takabatake H; Tagaki S; Sekine K
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1981-4. PubMed ID: 8978807
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
18. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.
Homesley HD; Bundy BN; Hurteau JA; Roth LM
Gynecol Oncol; 1999 Feb; 72(2):131-7. PubMed ID: 10021290
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin, actinomycin-D, and cisplatin treatment of ovarian germ-cell malignancies contributes to reducing adverse drug reactions.
Sumi T; Ishiko O; Yoshida H; Ogita S
Oncol Rep; 2000; 7(6):1235-8. PubMed ID: 11032921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
